TRPV1 and bone cancer: Conversely, TRPV1 activation may promote proinflammatory and pro-nociceptive effects as described in animal models of peripheral neuropathic pain (55) and bone cancer pain (56), and in human osteoarthritis and rheumatoid arthritis (57).